Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating

Gut

Volumn 66, Issue 5, 2016, Pages 980-982

  Holvoet, Tom ^a   Joossens, Marie ^b,c,d   Wang, Jun ^b,c   Boelens, Jerina ^a   Verhasselt, Bruno ^a   Laukens, Debby ^a   Van Vlierberghe, Hans ^a   Hindryckx, Pieter ^a   De Vos, Martine ^a   De Looze, Danny ^a   Raes, Jeroen ^b,c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BLOATING; CONTROLLED CLINICAL TRIAL (TOPIC); DIARRHEA; DISEASE DURATION; FECAL MICROBIOTA TRANSPLANTATION; FOLLOW UP; HUMAN; IRRITABLE COLON; LETTER; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS; ABDOMINAL PAIN; CONSTIPATION; FECES; FLATULENCE;

ABDOMINAL PAIN; CONSTIPATION; FECES; FLATULENCE; HUMANS; IRRITABLE BOWEL SYNDROME;

EID: 84981555669     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-312513     Document Type: Letter

References (8)

1. Halmos EP, Christophersen CT, Bird AR, et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015;64:93-100.
2. Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013;500:541-6.
3. McIntosh K, Reed DE, Schneider T, et al. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut 2016; Published Online First 14 March 2016.
4. Simrén M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013;62:159-76.
5. Ringel-Kulka T, Benson AK, Carroll IM, et al. Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating. Am J Physiol Gastrointest Liver Physiol 2016;310:G417-26.
6. Jeffery IB, O'Toole PW, Öhman L, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012;61: 997-1006.
7. Vermeire S, Joossens M, Verbeke K, et al. Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease. J Crohn Colitis 2016;10:387-94.
8. Shah E, Pimentel M. Placebo effect in clinical trial design for irritable bowel syndrome. J Neurogastroenterol Motil 2014;20:163-70.